Search
for
Sort by
Research 481–510 of 1000+
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights
- Worldwide Clinical and Real-World Exposure to Baricitinib
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- 724 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areata
- 008 Stratifying alopecia areata systemic treatments: Tailored approaches to disease severity
- Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
- Recalcitrant lichen planopilaris treated with upadacitinib: a case series
- Baricitinib as a treatment for myasthenia gravis: A case report
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Reporte de caso: alopecia areata universal tratada exitosamente con baricitinib
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Alopecia areata
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- Citrullination at the Inflammatory Skin Barrier
- ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata.
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- Review of efficacy of baricitinib in the treatment of alopecia areata